Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
15.72
+0.55 (3.63%)
Jun 23, 2026, 3:04 PM CST
SHE:003020 Market Cap
SHE:003020 has a market cap or net worth of 3.59 billion as of June 22, 2026. Its market cap has decreased by -18.73% in one year.
Market Cap
3.59B
Enterprise Value
3.32B
Revenue
1.55B
Ranking
n/a
PE Ratio
21.92
Stock Price
15.72
Market Cap Chart
Since December 15, 2020, SHE:003020's market cap has increased from 3.09B to 3.59B, an increase of 16.26%. That is a compound annual growth rate of 2.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 3.59B | -27.11% |
| Dec 31, 2025 | 4.92B | 42.42% |
| Dec 31, 2024 | 3.46B | -23.11% |
| Dec 29, 2023 | 4.49B | 13.63% |
| Dec 30, 2022 | 3.96B | -6.89% |
| Dec 31, 2021 | 4.25B | 33.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assure Tech (Hangzhou) | 3.83B |
| ChemPartner PharmaTech | 3.81B |
| Beijing Bohui Innovation Biotechnology Group | 3.64B |
| Kexing Biopharm | 3.62B |
| Hinova Pharmaceuticals | 3.52B |
| Shanghai Obio Technology (Group) Corp. | 3.50B |
| Shanghai Shen Lian Biomedical | 3.46B |
| Baolingbao Biology | 3.39B |